Seventeen strains of yellow fever virus were compared by immunoblotting using polyclonal and monoclonal antibodies. Strains originating in South America were readily distinguishable from African strains on the basis of differences in the envelope protein. The 17D vaccine strain and strains derived from it differed radically from the parent Asibi and other wild-type strains in that cells infected with 17D did not accumulate intact envelope protein. We suggest that failure to accumulate the major viral surface protein is due to its increased susceptibility to breakdown and that this property may be a contributing factor in the attenuation of the vaccine strains.
INTRODUCTION
Yellow fever (YF) virus is the prototype of the family Flaviviridae, which also includes 66 other viruses, many capable of producing severe illness such as dengue haemorrhagic fever, Japanese encephalitis, West Nile fever and tick-borne encephalitis. A highly effective live vaccine against YF exists (17D); nevertheless, YF outbreaks continue to occur in Africa, the Caribbean, and South and Central America. The 17D vaccine strain was derived empirically from wild-type Asibi virus (AS) by serial passage through mouse and chick embryo cells (Theiler & Smith, 1937) but the molecular basis for its attenuation is not known. Since no other safe and effective living flavivirus vaccine has been successfully developed, it would be helpful if the factors that determined attenuation of the 17D strain could be identified.
The YF viral envelope (E) protein is broadly cross-reactive within the family and induces the major protective immune response (Porterfield, 1980) . Monoclonal antibodies (MAbs) against E protein can distinguish vaccine strains from wild-type YF virus, and African from South American isolates E. A. Gould, unpublished results) , suggesting that there may be antigenic differences that correlate with differences in virulence. It has also been shown by radioimmunoprecipitation that strains of YF virus from South America can be distinguished from other YF virus strains on the basis of the electrophoretic mobility of the E protein (Deubel et al., 1987) . Furthermore, four geographical variants (topotypes) of YF virus have been described on the basis of RNA oligonucleotide mapping, representing strains from Senegal, Central Africa, Ivory Coast and America (Deubel et al., 1986) . Here, we have compared wildtype and vaccine-derived YF viruses by immunoblotting; we demonstrate differences in the electrophoretic mobility of E protein in viruses from different geographical regions, and show that 17D vaccine strains are distinct in their failure to accumulate intact E protein in infected cells. .
1" Unpublished data.
Immunoblotting. Samples (10 Ixl) of infected 20% mouse brain suspension in phosphate-buffered saline (PBS)
were mixed with 10 ~tl lysis buffer (10% glycerol, 1% SDS, 50 mM-Tris-HCl pH 7.5, 2 mM-PMSF, 1 mM-ETDA). Alternatively, infected Vero cell cultures were washed twice with PBS and then harvested directly into lysis buffer. Proteins were resolved on 12% SDS-PAGE gels (Laemmli, 1970) without the use of reducing agents, and subsequently electroblotted onto nitrocellulose paper which was then blocked with 5 % dried milk powder in PBS containing 0-2% Tween 20. Blots were incubated overnight at 4 °C with the first antibody, diluted in PBS containing 0.2% Tween 20 and 1% bovine serum albumin. They were washed with PBS containing 0.2% Tween 20 and then incubated for 90 rain at room temperature with affinity-purified goat anti-rabbit IgG (or anti-mouse IgG, as appropriate) linked to horseradish peroxidase (Bio-Rad), diluted as for the first antibody. Following extensive washing, the blots were developed using diaminobenzidine and hydrogen peroxide. Most epitopes on flavivirus E proteins appear to be sensitive to reduction so inclusion of reducing agents in the lysis buffer results in almost total loss of antibody binding (Srivastava et al., 1987) . As it was necessary to omit reducing agents, it was not possible to calculate precise Mr values. Viral proteins in this report have therefore been assigned apparent molecular mobilities for comparative purposes, calculated with reference to standard proteins electrophoresed under reducing conditions.
Antisera. Rabbit hyperimmune antiserum to partially purified l 7D (RH 1) and MAbs to YF virus were produced as previously described . Before use, RH1 was extensively absorbed with mouse liver powder.
MAbs were prepared as both ascitic fluids and tissue culture fluids. The molecular speeificities of the MAbs used to identify the various proteins in this study are summarized in Table 2 .
Virus Purification. Plaque-purified 17D and AS were grown on Vero cells in roller bottles. The culture supernatants were clarified and the virus was precipitated with polyethelene glycol. The virus pellet was resuspended, clarified by centrifugation in a microfuge, and the virus was then subjected to glycerol-tartrate (30 to 40 % w/v) density centrifugation (100000 g for 4 h). defined specificities (Cammack & Gould, 1986) , for virus infectivity in Vero cells, and by immunoblotting. Selected fractions from the gradient were diluted in PBS and then sedimented by ultracentrifugation at 100000 g for 2 h; the pellets were resuspended in lysis buffer and examined by immunoblotting using hyperimmune antiserum and MAbs specific for E or NS1 proteins.
RESULTS

Immunoblots of YF virus-infected brains
Each of the three categories of YF virus (i.e. 17D, wild-type African and wild-type South American) produced distinct patterns of viral proteins when tested as YF virus-infected brain suspensions by immunoblotting. All viruses listed in Table 1 were examined using hyperimmune antiserum (RH1). Representative strains are presented in Fig. 1 . Uninfected brain suspensions did not react with RH1 antiserum. African strains of YF virus had strongly reacting viral proteins with apparent mobilities of 49K, 39K and 25K, and also some diffusely stained bands between p39 and p49. YF virus strains from South America and Panama showed two proteins (apparent mobilities 49K and 51K to 52K), together with p39, p25 and a weak band with an apparent mobility of 41K. Interestingly, a Trinidadian isolate more closely resembled the African strains of YF virus than the South American strains. In contrast, all YF virus strains derived from the 17D vaccine, including the 17DD strains, showed no detectable p49, but they did show large quantities of the p39 and p25 viral proteins as seen with the other YF virus strains; there was also faint, diffuse virus-specific staining in the mobility range 40K to 46K. In separate analyses using MAbs, p49 of the African strains, p49 and p51-52 of the American strains, and p40-46 produced by the vaccine strains all reacted with E protein-specific MAb 813 whereas the p39 and p41 proteins reacted with NSl-specific MAbs 863 and 979.
Virus infectivities in each preparation are shown in Table 3 . There was no clear correlation between the intensity of staining in the immunoblot and the virus titre as determined in Vero cells; for example, even low titre wild-type YF virus produced distinct E-specific bands. Thus, lack of accumulation of E protein in the 17D samples could not be accounted for by failure to produce infectious virus. The apparently low titres of some wild-type strains, as titrated in Vero cells, possibly reflect lack of adaptation of mammalian cell culture systems, since their infectivities in mosquito cell cultures were higher (data not shown). 
Immunoblots of YF virus-infected tissue culture cells
The production of virus-specific proteins in Vero cell cultures by AS and 17D was then compared by immunoblotting with RH1 antiserum. AS-infected cells accumulated large amounts of intact E protein, together with NS1 and, at 24 and 48 h, p25; at 72 h, p25 was replaced by a slightly faster migrating protein. In contrast, 17D-infected cultures failed to accumulate significant amounts of intact E protein, (although occasionally small quantities of intact E protein were detected), despite producing similar intensities of NS1 and p25 labelling (Fig. 2 ). This occurred with standard vaccine and with three times plaque-purified virus, and also when various multiplicities of infection were used. With these 17D-infected preparations, E-reactive polypeptides with apparent mobilities of 42K to 45K were seen (Fig. 3) ; these 42K to 45K polypeptides were always more evident in the tissue culture samples than in the infected brain samples.
Immunoblots of purified YF virus
Gradient-purified, tissue culture-derived 17D and AS viruses were compared by immunoblotting. Fig. 4 shows an analysis of 17D samples from a glycerol-tartrate gradient examined by ELISA tests, using appropriate MAbs, and virus infectivity titrations. Most of the infectious virus was concentrated in fractions 2 to 5. ELISA results showed a peak of E-reactive epitopes in fractions 2 and 3. Interestingly, MAb 612 produced a very narrow band of activity whilst all other E-specific MAb gave a broader band. Since MAb 612 neutralizes virus infectivity we interpret this as indicating the position of the virions. NSl-reactive protein was found only in the upper fractions of the gradient. By immunoblotting of gradient fractions directly, it was difficult to detect virus-specific proteins due to the relative insensitivity of this technique compared with ELISA. However, immunoblots of pellets obtained by centrifugation from fractions 2, 4 and 6 showed a very strong but diffuse E-specific band with relative mobility 42K to 45K (Fig. 5a) ; no reaction with NSl-specific MAb could be detected in these pelleted samples. Fig. 6 shows a similar analysis using gradient-purified AS virus. Virus infectivity was concentrated in fraction 2. By ELISA tests, E-specific MAbs produced two peaks corresponding to the virions and the slower sedimenting membrane-bound E protein. Immunoblots (Fig. 5 b) of pelleted fractions 2, 4 and 6 showed intact E protein of relative mobility 49K to 50K. There was no detectable degradation of the E protein. Moreover, the intensity of staining of the E protein bands, from the various fractions, paralleled the reaction profiles obtained in the ELISA tests.
DISCUSSION
By immunoblotting with appropriate antibodies, we have demonstrated significant differences in the accumulation of viral E protein by cells infected with wild-type strains of YF virus and 17D vaccine strains: cells infected with 17D-derived vaccines showed little detectable intact E protein whereas those infected with wild-type YF virus strains from both West Africa and South America and the FNV vaccine strain showed heavily labelled intact E protein bands. The finding that FNV resembles wild-type viruses is not surprising, since it exhibits high neurovirulence in mice (Gould et al., 1987) . Lack of intact E protein does not necessarily mean complete lack of the antigenic determinants in cells infected with 17D since smaller polypeptides bearing some epitopes were readily detected. Our results, however, could explain the observations of Clarke (1960) who reported that excessively large amounts of 17D, as opposed to wild-type-infected mouse brain antigen, were required to remove haemagglutinationinhibiting (E-specific) homologous antibody by absorption. Immunoblotting also showed slight differences in the sizes of the degradation products of the 17D and 17DD E proteins, possibly reflecting the genetic variations between these strains .
Using radioimmunoprecipitation, it has been shown that 17D-infected cultures do produce intact E protein, with an apparent mobility under reducing conditions of 54K Gould et al., 1985) , and we can readily reproduce this result (data not shown). Thus, failure to detect intact E protein in 17D-infected preparations by immunoblotting probably reflects its lack of accumulation due to rapid breakdown, rather than lack of production. The presence of the smaller E-related polypeptides in the immunoblots (see Fig. 3 ) supports this concept. Similar E-related polypeptides sized 42K to 46K were shown to be immunoprecipitated by MAb 813, also indicating breakdown of the E protein . Whether or not these differences in apparent stability of the E proteins of vaccine and wild-type strains can account for the differences in virulence remains to be determined.
Several attempts were made to detect intact E protein in 17D by concentration and purification of virions using glycerol-tartrate gradients. ELISA analysis of fractions from these gradients localized the virion and non-virion proteins. However, by immunoblotting, only wildtype YF virus showed significant quantities of intact E protein in the region corresponding to the virion. Interestingly, the gradient preparations of 17D, but not AS, showed that MAb 612 labelled virion in preference to non-virion E protein, whereas MAb 813 labelled both virion and non-virion E proteins. Moreover, the ELISA analysis showed that with 17D preparations, E protein was dispersed as a broad band in the gradient probably representing large quantities of degraded E protein that remain associated with the virus particles. This is supported by Wengler et al. (1987) who showed that if West Nile virus was treated with chymotrypsin a 42K fragment of the E protein was generated which remained associated with the virus particle. Dispersal of E protein in AS gradient preparations was less noticeable, perhaps reflecting the more homogeneous characteristics of its E protein.
According to Hahn et al. (1987) , the nucleotide sequence differences between AS and 17D viruses give rise to 32 amino acid differences, 12 of which occur in the E protein. Two of these amino acid changes (numbers 380 and 390) lie in a region of the E protein which, for West Nile virus, is susceptible to attack by proteases leading to the appearance of a 42K cleavage product (Wengler et al., 1987) . Therefore, it may be that some of the amino acid changes in 17D have made its E protein more susceptible to proteolysis than that of wild-type YF virus strains.
It is possible that failure to detect complete E protein in 17D-infected cells is due to breakdown of the protein in the gel system rather than in vivo. This seems unlikely since intact E proteins were demonstrable with all other flaviviruses examined (data not shown) and intact E protein of 17D is detectable by PAGE analysis when radioactively pulse-labelled. Nevertheless, if our failure to detect intact E protein in 17D-infected cells by immunoblotting is due to in vitro breakdown, the differences observed between 17D and its wild-type parent AS must still reflect a fundamental difference in the stability of their E proteins.
A further possible explanation is that the lack of complete E protein in 17D-infected cells is due to the production of defective interfering particles. This seems unlikely since plaquepurified virus with high infectivity titres also produced almost no complete E protein when analysed by immunoblotting.
The demonstration of a double E-specific protein band in the South American YF virus strains confirms and extends the report of Deubel et al. (1987) . It is interesting that the Trinidadian isolate used in our work resembled YF virus isolates from West Africa whereas that examined by Deubel et al. (1987) resembled South American YF virus, implying the presence of both African and South American strains in Trinidad.
The 17D vaccine was derived after many serial passages through mouse and chicken tissue and the basis for its attenuation therefore is almost certainly multifactorial. Fitzgeorge & Bradish (1980) concluded that 'the 17D vaccine strain appears as a selection or variant of greatly impaired efficiency of infection and stimulation yet unchanged capacity to involve the target site once infection is established.' Such properties of a vaccine could be partly accounted for by the apparent instability of the major viral surface protein described in this report.
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